Augmentation of Exposure Therapy With D-Cycloserine in Patients With Agoraphobia With or Without Panic Disorder
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2014
Price : $35 *
At a glance
- Drugs Cycloserine (Primary)
- Indications Agoraphobia; Panic disorder
- Focus Therapeutic Use
- Acronyms Exposure-DCS
- 16 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Mar 2014 Planned End Date changed from 1 Nov 2013 to 1 May 2014 as reported by ClinicalTrials.gov record.
- 01 Sep 2013 New trial record